Mirae Asset Global ETFs Holdings
IMNM icon

Mirae Asset Global ETFs Holdings’s Immunome IMNM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
58,200
-762
-1% -$16.3K ﹤0.01% 1524
2026
Q1 		$1.26M Buy
58,962
+8,825
+18% +$196K ﹤0.01% 1409
2025
Q4 		$1.07M Buy
50,137
+9,838
+24% +$173K ﹤0.01% 1472
2025
Q3 		$470K Sell
40,299
-3,794
-9% -$37.7K ﹤0.01% 1894
2025
Q2 		$408K Sell
44,093
-2,728
-6% -$22.4K ﹤0.01% 1914
2025
Q1 		$316K Buy
46,821
+14,398
+44% +$138K ﹤0.01% 2086
2024
Q4 		$343K Buy
32,423
+692
+2% +$8.36K ﹤0.01% 2101
2024
Q3 		$463K Buy
31,731
+27,362
+626% +$389K ﹤0.01% 1954
2024
Q2 		$52.3K Buy
+4,369
New +$68.3K ﹤0.01% 2781

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's IMNM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Immunome (IMNM) stake by 1.3% in Q2 2026, selling an estimated $16.3K and leaving 58,200 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Mirae Asset Global ETFs Holdings first reported a position in IMNM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.26M in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 58,200 shares of Immunome worth $1.23M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 762 Immunome shares in Q2 2026, an estimated $16.3K.
  • Immunome made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1524 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Immunome in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Immunome position peaked at $1.26M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.